Md. board hopes to identify first round of prescription drugs for price evaluations in 2024

A state board tasked with controlling prescription drug prices for Maryland workers said that they are likely to identify the first set of medications for cost reduction efforts in early next year, and the panel is finalizing procedures in order to get their work underway. The Prescription Drug Affordability Board put the final stamp on two rules outlining the initial procedures to start evaluating which drugs are not affordable for state workers during a virtual meeting Monday.